Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $16.0 million.

  • Rallybio's Profit After Tax rose 23968.25% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.2 million, marking a year-over-year increase of 7881.63%. This contributed to the annual value of -$57.8 million for FY2024, which is 2252.01% up from last year.
  • According to the latest figures from Q3 2025, Rallybio's Profit After Tax is $16.0 million, which was up 23968.25% from -$9.7 million recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Profit After Tax peaked at $16.0 million during Q3 2025, and registered a low of -$20.3 million during Q4 2023.
  • For the 3-year period, Rallybio's Profit After Tax averaged around -$12.3 million, with its median value being -$16.2 million (2024).
  • In the last 5 years, Rallybio's Profit After Tax crashed by 987.99% in 2024 and then skyrocketed by 23968.25% in 2025.
  • Over the past 3 years, Rallybio's Profit After Tax (Quarter) stood at -$20.3 million in 2023, then surged by 45.41% to -$11.1 million in 2024, then skyrocketed by 244.69% to $16.0 million in 2025.
  • Its Profit After Tax stands at $16.0 million for Q3 2025, versus -$9.7 million for Q2 2025 and -$9.4 million for Q1 2025.